Moderate riskFDA DrugClass II

Blaine Labs TERPENICOL antifungal cream recalled for CGMP deviations

Blaine Labs is recalling TERPENICOL Antifungal Cream because the firm stopped required stability testing for products still within their expiration dates. The recall is classified by FDA as Class II and covers 22,143 bottles distributed nationwide in the USA. The notice does not report any injuries.

From the FDA notice · Read the official notice ↗

What to do

  1. Stop using bottles of TERPENICOL Antifungal Cream from the affected lots.
  2. Check the lot number and expiration date on the bottle. Affected lots are BL3431R (exp 10/13/26) and BL3528 (exp 08/30/2027). NDC 63347-601-01.
  3. The notice doesn't say how to get a refund or replacement. Contact Blaine Labs, Inc. or the place you bought the product.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
TERPENICOL Antifungal Cream (Undecylenic Acid 13%), 1.0 oz (28 g) bottles, Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Sante Fe Springs, CA 90670, NDC 63347-601-01.
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 8 products — see all of them.

Details

Units affected
22,143 bottles
Illnesses reported
None reported
Manufactured in
11037 Lockport Pl, N/A, Santa Fe Springs, CA, United States
Classification
Class II
Recall number
D-0695-2026

In the FDA's words

Description
TERPENICOL Antifungal Cream (Undecylenic Acid 13%), 1.0 oz (28 g) bottles, Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Sante Fe Springs, CA 90670, NDC 63347-601-01. CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry Lots BL3431R, Exp Date 10/13/26 & BL3528, Exp Date 08/30/2027. Distribution: Nationwide in the USA Affected quantity: 22,143 bottles
Hazard
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

8 products in this recall

Revitaderm, Terpenicol and more recalled for microbial contamination

Eight Blaine Labs and Trifluent Pharma wound care and antifungal products are recalled: Revitaderm, TRIDERGEL, TRIPENICOL S, TERPENICOL, vite20, Fungal Fusion and Revitaderm First Aid Antiseptic Gel. Samples of these non-sterile products showed Lysinibacillus fusiformis and other Bacillus species. The FDA has classified this as a Class I recall.

The agency lists each product separately. Check every one you might have.

Related topics

OtherPotencyDrugsSold nationwideMore from FDA Drug